Anantharaman K. Sitagliptin: The First in a New Class of DPP-4 Inhibitors for the Treatment of Type 2 Diabetes. KMJ [Internet]. 30Sep.2008 [cited 23Dec.2024];1(1):33-4. Available from: https://www.keralamedicaljournal.com/index.php/KMJ/article/view/98